These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34328373)

  • 1. Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
    Echeverria-Esnal D; Martín-Ontiyuelo C; Navarrete-Rouco ME; Barcelo-Vidal J; Conde-Estévez D; Carballo N; De-Antonio Cuscó M; Ferrández O; Horcajada JP; Grau S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):179-197. PubMed ID: 34328373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
    Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
    Pettit NN; Carver PL
    Ann Pharmacother; 2015 Jul; 49(7):825-42. PubMed ID: 25940222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Sherif R; Segal BH
    Curr Opin Pulm Med; 2010 May; 16(3):242-50. PubMed ID: 20375786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Isavuconazole for the treatment of invasive
    Sivasubramanian G; Chandrasekar PH
    Expert Opin Pharmacother; 2022 Apr; 23(5):543-549. PubMed ID: 35099351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the treatment of chronic pulmonary aspergillosis.
    Armstrong-James D; Kosmidis C; Bromley M
    Curr Opin Infect Dis; 2023 Apr; 36(2):146-151. PubMed ID: 36912585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
    Seyedmousavi S; Mouton JW; Verweij PE; Brüggemann RJ
    Expert Rev Anti Infect Ther; 2013 Sep; 11(9):931-41. PubMed ID: 24053274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
    Godet C; Goudet V; Laurent F; Le Moal G; Gounant V; Frat JP; Cateau E; Roblot F; Cadranel J
    Mycoses; 2015 Mar; 58(3):173-80. PubMed ID: 25690951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of the antifungals used in the treatment of aspergillosis].
    Azanza JR; Sádaba B; Gómez-Guíu A
    Rev Iberoam Micol; 2014; 31(4):255-61. PubMed ID: 25442382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Kohno S; Izumikawa K; Takazono T; Miyazaki T; Yoshida M; Kamei K; Ogawa K; Taniguchi S; Akashi K; Tateda K; Mukae H; Miyazaki Y; Okada F; Kanda Y; Kakeya H; Suzuki J; Kimura SI; Kishida M; Matsuda M; Niki Y
    J Infect Chemother; 2023 Feb; 29(2):163-170. PubMed ID: 36307059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Ullmann AJ; Aguado JM; Arikan-Akdagli S; Denning DW; Groll AH; Lagrou K; Lass-Flörl C; Lewis RE; Munoz P; Verweij PE; Warris A; Ader F; Akova M; Arendrup MC; Barnes RA; Beigelman-Aubry C; Blot S; Bouza E; Brüggemann RJM; Buchheidt D; Cadranel J; Castagnola E; Chakrabarti A; Cuenca-Estrella M; Dimopoulos G; Fortun J; Gangneux JP; Garbino J; Heinz WJ; Herbrecht R; Heussel CP; Kibbler CC; Klimko N; Kullberg BJ; Lange C; Lehrnbecher T; Löffler J; Lortholary O; Maertens J; Marchetti O; Meis JF; Pagano L; Ribaud P; Richardson M; Roilides E; Ruhnke M; Sanguinetti M; Sheppard DC; Sinkó J; Skiada A; Vehreschild MJGT; Viscoli C; Cornely OA
    Clin Microbiol Infect; 2018 May; 24 Suppl 1():e1-e38. PubMed ID: 29544767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis.
    Bellmann R
    Curr Pharm Des; 2013; 19(20):3629-47. PubMed ID: 23278532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
    Otu AA; Langridge P; Denning DW
    Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
    Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
    Karthaus M
    Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Chronic Pulmonary Aspergillosis With Isavuconazole.
    Guillen Vera D; Ruiz Ruigómez M; García Moguel I; Morales Ruiz R; Corbella L; Fernández Rodríguez C
    J Investig Allergol Clin Immunol; 2019; 29(6):459-460. PubMed ID: 31172952
    [No Abstract]   [Full Text] [Related]  

  • 20. The spectrum of pulmonary aspergillosis.
    Kanj A; Abdallah N; Soubani AO
    Respir Med; 2018 Aug; 141():121-131. PubMed ID: 30053957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.